145 related articles for article (PubMed ID: 29767233)
1. Potential role of cyclin F mRNA expression in the survival of skin melanoma patients: Comprehensive analysis of the pathways altered due to cyclin F upregulation.
Gagat M; Krajewski A; Grzanka D; Grzanka A
Oncol Rep; 2018 Jul; 40(1):123-144. PubMed ID: 29767233
[TBL] [Abstract][Full Text] [Related]
2. Cyclin F is involved in response to cisplatin treatment in melanoma cell lines.
Krajewski A; Gagat M; Żuryń A; Hałas-Wiśniewska M; Grzanka D; Grzanka A
Oncol Rep; 2020 Mar; 43(3):765-772. PubMed ID: 32020229
[TBL] [Abstract][Full Text] [Related]
3. A cyclin without cyclin-dependent kinases: cyclin F controls genome stability through ubiquitin-mediated proteolysis.
D'Angiolella V; Esencay M; Pagano M
Trends Cell Biol; 2013 Mar; 23(3):135-40. PubMed ID: 23182110
[TBL] [Abstract][Full Text] [Related]
4. Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair.
D'Angiolella V; Donato V; Forrester FM; Jeong YT; Pellacani C; Kudo Y; Saraf A; Florens L; Washburn MP; Pagano M
Cell; 2012 May; 149(5):1023-34. PubMed ID: 22632967
[TBL] [Abstract][Full Text] [Related]
5. ATR-CHK1-E2F3 signaling transactivates human ribonucleotide reductase small subunit M2 for DNA repair induced by the chemical carcinogen MNNG.
Gong C; Liu H; Song R; Zhong T; Lou M; Wang T; Qi H; Shen J; Zhu L; Shao J
Biochim Biophys Acta; 2016 Apr; 1859(4):612-26. PubMed ID: 26921499
[TBL] [Abstract][Full Text] [Related]
6. Examining transcriptional changes to DNA replication and repair factors over uveal melanoma subtypes.
Kucherlapati M
BMC Cancer; 2018 Aug; 18(1):818. PubMed ID: 30107825
[TBL] [Abstract][Full Text] [Related]
7. Cancer-testis antigen MAGE-C2 binds Rbx1 and inhibits ubiquitin ligase-mediated turnover of cyclin E.
Hao J; Song X; Wang J; Guo C; Li Y; Li B; Zhang Y; Yin Y
Oncotarget; 2015 Dec; 6(39):42028-39. PubMed ID: 26540345
[TBL] [Abstract][Full Text] [Related]
8. Triptolide induced DNA damage in A375.S2 human malignant melanoma cells is mediated via reduction of DNA repair genes.
Chueh FS; Chen YL; Hsu SC; Yang JS; Hsueh SC; Ji BC; Lu HF; Chung JG
Oncol Rep; 2013 Feb; 29(2):613-8. PubMed ID: 23233170
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation.
Albino AP; Juan G; Traganos F; Reinhart L; Connolly J; Rose DP; Darzynkiewicz Z
Cancer Res; 2000 Aug; 60(15):4139-45. PubMed ID: 10945621
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance.
Li W; Melton DW
Oncogene; 2012 May; 31(19):2412-22. PubMed ID: 21996734
[TBL] [Abstract][Full Text] [Related]
11. Interleukin enhancer-binding factor 2 promotes cell proliferation and DNA damage response in metastatic melanoma.
Zhang X; Bustos MA; Gross R; Ramos RI; Takeshima TL; Mills GB; Yu Q; Hoon DSB
Clin Transl Med; 2021 Oct; 11(10):e608. PubMed ID: 34709752
[TBL] [Abstract][Full Text] [Related]
12. Expression of growth arrest and DNA damage genes and DNA mismatch repair genes in snake melanomas.
Korabiowska M; Brinck U; Frye FL; Harshbarger JC; Droese M; Kaiser HE
In Vivo; 1998; 12(5):539-42. PubMed ID: 9827364
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I induces cyclin-D1 expression in MG63 human osteosarcoma cells in vitro.
Furlanetto RW; Harwell SE; Frick KK
Mol Endocrinol; 1994 Apr; 8(4):510-7. PubMed ID: 8052269
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D.
Georgantas RW; Streicher K; Luo X; Greenlees L; Zhu W; Liu Z; Brohawn P; Morehouse C; Higgs BW; Richman L; Jallal B; Yao Y; Ranade K
Pigment Cell Melanoma Res; 2014 Mar; 27(2):275-86. PubMed ID: 24289491
[TBL] [Abstract][Full Text] [Related]
16. siRNA knockdown of ribonucleotide reductase inhibits melanoma cell line proliferation alone or synergistically with temozolomide.
Zuckerman JE; Hsueh T; Koya RC; Davis ME; Ribas A
J Invest Dermatol; 2011 Feb; 131(2):453-60. PubMed ID: 20944646
[TBL] [Abstract][Full Text] [Related]
17. Pathway aberrations of murine melanoma cells observed in Paired-End diTag transcriptomes.
Chiu KP; Ariyaratne P; Xu H; Tan A; Ng P; Liu ET; Ruan Y; Wei CL; Sung WK
BMC Cancer; 2007 Jun; 7():109. PubMed ID: 17594473
[TBL] [Abstract][Full Text] [Related]
18. Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma.
Cheng PF; Shakhova O; Widmer DS; Eichhoff OM; Zingg D; Frommel SC; Belloni B; Raaijmakers MI; Goldinger SM; Santoro R; Hemmi S; Sommer L; Dummer R; Levesque MP
Genome Biol; 2015 Feb; 16(1):42. PubMed ID: 25885555
[TBL] [Abstract][Full Text] [Related]
19. Human three prime exonuclease TREX1 is induced by genotoxic stress and involved in protection of glioma and melanoma cells to anticancer drugs.
Tomicic MT; Aasland D; Nikolova T; Kaina B; Christmann M
Biochim Biophys Acta; 2013 Aug; 1833(8):1832-43. PubMed ID: 23578789
[TBL] [Abstract][Full Text] [Related]
20. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells.
Jiang H; Lin J; Su ZZ; Herlyn M; Kerbel RS; Weissman BE; Welch DR; Fisher PB
Oncogene; 1995 May; 10(9):1855-64. PubMed ID: 7753561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
